Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
about
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
description
clinical trial
@en
klinisch onderzoek
@nl
name
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
@en
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
@nl
type
label
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
@en
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
@nl
prefLabel
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
@en
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
@nl
P1050
P1476
Rituximab (Anti-CD20) for the ...... ed Cryoglobulinemic Vasculitis
@en
P3098
NCT00029107
P4844
P580
2001-12-01T00:00:00Z
P582
2011-05-01T00:00:00Z